Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

NCT05357612 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Neurodegenerative Diseases
Parkinson Disease
Parkinson Disease Psychosis

Interventions

DRUG: Pimavanserin

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]